Venkys (India) is setting up a new project for manufacture of Veterinary Medicine Products under its Animal Health Product Segment. The Company has acquired land admeasuring 15030 Sqm at MIDC, Village: Kesurdi, Tal: Khandala, District: Satara, Maharashtra for this purpose.
Construction activities will commence in December 2021 and it is expected that the project will be completed by March 2022 and commercial production will commence by June 2022.
This project is to manufacture Veterinary Medicines Powders (600 Tonnes/Annum) and Veterinary Medicines Liquids (300 Kilolitres I Annum) to cater the growing demand from poultry industry.
Total cost of the project is estimated at Rs. 30 crore which will be funded from internal accruals.
The proposed plant will be the second one from the Company and will be in compliance with the latest FDA regulation and expected to cater export needs also. The Company has already one plant located in Pune (Maharashtra) with a capacity of 600 Tonnes/Annum and the said capacity is utilized to the extent of 70-80%.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU